PPARD and metabolic syndrome: The obtained data of the in vivo and in vitro studies suggest that XH601 exhibited strong ability to improve the dyslipidemia in hamsters fed with high-fat diet and the hypolipidemic mechanisms of XH601 were associated with the up-regulation of PPARα and PPARβ/δ expression.